13F-HR filed by Artal Group S.A.
Artal Group S.A. filed this 13F-HR for the quarter ended 2020-03-31, filed 2020-05-14, with 103 holding rows worth $2,366,281,000.
- Accession
- 0001053906-20-000006
- Filer
- CIK 1053906
- Filed
- 2020-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2020
A holdings report, 105 entries on the cover page, a total value of $2,366,281,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $2,366,280,000 with VALUE read as thousands by filing date, 13F file number 028-15027. The quarter's positions are built on this report. The resolved quarter.
Other managers
- included managerStichting Administratiekantoor Westend028-15028
- included managerWestend S.A.028-15029
- included managerArtal International Management S.A.028-15031
- included managerArtal International S.C.A.028-15033
- included managerArtal Treasury Ltd028-19088
- included managerInvus Public Equities Advisors, LLC028-11522
- included managerArtal Luxembourg S. A.028-19506
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| WW INTL INC | 98262P101 | COM | 14,818,300 | $250,577,000 | thousands by filing date | |
| ACCELERON PHARMA INC | 00434H108 | COM | 1,500,000 | $134,805,000 | thousands by filing date | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 2,228,130 | $130,123,000 | thousands by filing date | |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 1,100,000 | $119,735,000 | thousands by filing date | |
| LEXICON PHARMACEUTICALS INC | 528872302 | COMMON STOCK | 60,240,864 | $117,470,000 | thousands by filing date | |
| MODERNA INC | 60770K107 | COM | 3,000,000 | $89,850,000 | thousands by filing date | |
| BEONE MEDICINES LTD SPONSORED ADS | 07725L102 | ADR | 650,000 | $80,022,000 | thousands by filing date | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 400,000 | $77,792,000 | thousands by filing date | |
| ALIBABA GROUP HLDG LTD | 01609W102 | SPONSORED ADS | 400,000 | $77,792,000 | thousands by filing date | call |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 475,000 | $62,572,000 | thousands by filing date | |
| AVANTOR INC COM | 05352A100 | Stock | 4,500,000 | $56,205,000 | thousands by filing date | |
| UNIQURE NV | N90064101 | SHS | 1,150,000 | $54,568,000 | thousands by filing date | |
| FATE THERAPEUTICS INC | 31189P102 | COM | 2,100,000 | $46,641,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 5,000,000 | $46,200,000 | thousands by filing date | |
| Bank of America Corp | 060505104 | COM | 2,000,000 | $42,460,000 | thousands by filing date | call |
| BLACK DIAMOND THERAPEUTICS I | 09203E105 | COM | 1,696,517 | $42,328,000 | thousands by filing date | |
| PAYPALHLDGSINC | 70450Y103 | STOK | 440,000 | $42,126,000 | thousands by filing date | |
| SPDR SER TR | 78464A870 | S&P BIOTECH | 500,000 | $38,720,000 | thousands by filing date | call |
| SCHRODINGER INC COM | 80810D103 | Stock | 897,445 | $38,698,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 2,300,000 | $35,673,000 | thousands by filing date | |
| SELECT SECTOR SPDR TR | 81369Y704 | INDL | 600,000 | $35,406,000 | thousands by filing date | call |
| DECIPHERA PHARMACEUTICALS IN | 24344T101 | COM | 800,000 | $32,936,000 | thousands by filing date | |
| ZILLOW GROUP INC CL C CAP STK | 98954M200 | Stock | 900,000 | $32,418,000 | thousands by filing date | |
| SCHOLAR ROCK HLDG CORP | 80706P103 | COM | 2,546,040 | $30,833,000 | thousands by filing date | |
| MORPHIC HLDG INC | 61775R105 | COM | 1,819,186 | $26,706,000 | thousands by filing date | |
| MasterCard, Inc | 57636Q104 | COM | 100,000 | $24,156,000 | thousands by filing date | call |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 400,000 | $23,392,000 | thousands by filing date | |
| IOVANCE BIOTHERAPEUTICS INC | 462260100 | COM | 750,000 | $22,451,000 | thousands by filing date | |
| ATARA BIOTHERAPEUTICS INC COM NEW | 046513107 | Stock | 2,500,000 | $21,275,000 | thousands by filing date | |
| FIBROGEN INC | 31572Q808 | COM | 600,000 | $20,850,000 | thousands by filing date | |
| GOSSAMER BIO INC COM | 38341P102 | Stock | 1,808,968 | $18,361,000 | thousands by filing date | |
| RUBIUS THERAPEUTICS INC | 78116T103 | COM | 3,883,791 | $17,283,000 | thousands by filing date | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 600,000 | $17,262,000 | thousands by filing date | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 200,000 | $16,900,000 | thousands by filing date | call |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 550,000 | $15,950,000 | thousands by filing date | |
| PRINCIPIA BIOPHARMA INC | 74257L108 | COM | 250,000 | $14,845,000 | thousands by filing date | |
| AGIOS PHARMACEUTICALS INC | 00847X104 | COM | 400,000 | $14,192,000 | thousands by filing date | |
| HARPOON THERAPEUTICS INC | 41358P106 | COM | 1,200,000 | $13,896,000 | thousands by filing date | |
| VNET GROUP INC | 90138A103 | SPONSORED ADS A | 1,000,000 | $13,860,000 | thousands by filing date | |
| TURNING PT THERAPEUTICS | 90041T108 | COM | 300,000 | $13,398,000 | thousands by filing date | |
| BLUEPRINT MEDICINES CORP | 09627Y109 | COM | 200,000 | $11,696,000 | thousands by filing date | call |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 100,000 | $11,261,000 | thousands by filing date | |
| Uber Technologies | 90353T100 | COM | 400,000 | $11,168,000 | thousands by filing date | |
| TRIP COM GROUP LTD ADS | 89677Q107 | ADR | 465,000 | $10,904,000 | thousands by filing date | |
| AURINIA PHARMACEUTICALS INC COM | 05156V102 | Stock | 750,000 | $10,883,000 | thousands by filing date | |
| Y-mAbs Therapeutics Inc | 984241109 | Common Stock | 400,000 | $10,440,000 | thousands by filing date | |
| SAGE THERAPEUTICS INC | 78667J108 | COM | 350,000 | $10,052,000 | thousands by filing date | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 1,000,000 | $9,840,000 | thousands by filing date | |
| ALBIREO PHARMA INC | 01345P106 | COMMON STOCK | 588,125 | $9,628,000 | thousands by filing date | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 350,000 | $9,450,000 | thousands by filing date | |
| AMICUS THERAPEUTICS INC | 03152W109 | COM | 1,000,000 | $9,240,000 | thousands by filing date | call |
| DENALI THERAPEUTICS INC COM | 24823R105 | Stock | 500,000 | $8,755,000 | thousands by filing date | |
| STONECO LTD | G85158106 | COM CL A | 400,000 | $8,708,000 | thousands by filing date | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 1,450,000 | $8,352,000 | thousands by filing date | |
| SELECTA BIOSCIENCES INC | 816212104 | COM | 3,413,629 | $8,227,000 | thousands by filing date | |
| REGENXBIO INC | 75901B107 | COM | 250,000 | $8,095,000 | thousands by filing date | |
| TRICIDA INC | 89610F101 | COM | 360,000 | $7,920,000 | thousands by filing date | |
| PROQR THERAPEUTICS NV | N71542109 | SHS EURO | 1,300,000 | $7,137,000 | thousands by filing date | |
| AC IMMUNE SA | H00263105 | SHS | 1,000,000 | $6,910,000 | thousands by filing date | |
| HOOKIPA PHARMA INC | 43906K100 | COM | 796,259 | $6,569,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 1,000,000 | $6,360,000 | thousands by filing date | |
| MELCO RESORTS & ENTERTAINMENT | 585464100 | ADR | 500,000 | $6,200,000 | thousands by filing date | call |
| AGENUS INC | 00847G705 | COM NEW | 2,500,000 | $6,125,000 | thousands by filing date | |
| AMERICAN AIRLINES GROUP INC COM | 02376R102 | Stock | 500,000 | $6,095,000 | thousands by filing date | call |
| MERUS N V | N5749R100 | COM | 500,000 | $6,050,000 | thousands by filing date | |
| ALECTOR INC | 014442107 | COMMON STOCK | 250,000 | $6,033,000 | thousands by filing date | |
| MINERVA NEUROSCIENCES INC COM NEW | 603380106 | Stock | 1,000,000 | $6,020,000 | thousands by filing date | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 600,000 | $5,982,000 | thousands by filing date | |
| TRANSLATE BIO INC. | 89374L104 | Common Stock | 600,000 | $5,982,000 | thousands by filing date | |
| Adverum Biotechnologies, Inc. | 00773U108 | Common Stock | 600,000 | $5,862,000 | thousands by filing date | |
| STOKE THERAPEUTICS INC | 86150R107 | COM | 250,000 | $5,725,000 | thousands by filing date | |
| ADAPTIVE BIOTECHNOLOGIES CORP COM | 00650F109 | Stock | 200,000 | $5,556,000 | thousands by filing date | |
| Accelerate Diagnostics | 00430H102 | COM | 600,000 | $4,998,000 | thousands by filing date | |
| CYCLERION THERAPEUTICS INC | 23255M105 | COM | 1,861,584 | $4,933,000 | thousands by filing date | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 576,000 | $4,654,000 | thousands by filing date | |
| BLUEBIRD BIO INC | 09609G100 | COM | 100,000 | $4,596,000 | thousands by filing date | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 350,000 | $4,550,000 | thousands by filing date | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 100,000 | $4,324,000 | thousands by filing date | |
| SOLID BIOSCIENCES INC COM NEW | 83422E105 | Stock | 1,800,000 | $4,302,000 | thousands by filing date | |
| 111 INC | 68247Q102 | ADR | 650,000 | $4,297,000 | thousands by filing date | |
| TRILLIUM THERAPEUTICS INC COM NEW | 89620X506 | Stock | 1,000,000 | $4,040,000 | thousands by filing date | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 400,000 | $3,980,000 | thousands by filing date | |
| PASSAGE BIO INC | 702712100 | COM | 250,000 | $3,938,000 | thousands by filing date | |
| EPIZYME INC | 29428V104 | COM | 250,000 | $3,878,000 | thousands by filing date | call |
| IMMUNIC INC | 4525EP101 | COM | 630,019 | $3,812,000 | thousands by filing date | |
| APTINYX INC | 03836N103 | COM | 1,666,666 | $3,600,000 | thousands by filing date | |
| AKEBIA THERAPEUTICS INC | 00972D105 | COMMON STOCK | 425,000 | $3,222,000 | thousands by filing date | |
| PROTHENA CORP PLC SHS | G72800108 | Stock | 300,000 | $3,210,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 500,000 | $3,180,000 | thousands by filing date | call |
| TCR2 THERAPEUTICS INC | 87808K106 | COM | 400,000 | $3,096,000 | thousands by filing date | |
| KALEIDO BIOSCIENCES INC | 483347100 | COM | 500,500 | $3,078,000 | thousands by filing date | |
| ORCHARD THERAPEUTICS PLC | 68570P101 | ADR | 400,000 | $3,012,000 | thousands by filing date | |
| SYROS PHARMACEUTICALS INC | 87184Q107 | COM | 506,138 | $3,001,000 | thousands by filing date | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 500,000 | $2,995,000 | thousands by filing date | |
| CHINOOK THERAPEUTICS INC. | 00739L101 | Common Stock | 1,000,000 | $2,740,000 | thousands by filing date | |
| PREVAIL THERAPEUTICS INC | 74140Y101 | COM | 200,000 | $2,438,000 | thousands by filing date | |
| AXCELLA HEALTH INC | 05454B105 | COM | 600,000 | $2,052,000 | thousands by filing date | |
| AEGLEA BIOTHERAPEUTICS INC | 00773J103 | COM | 400,000 | $1,864,000 | thousands by filing date | |
| PORTOLA PHARMACEUTICALS INC COM | 737010108 | Stock | 200,000 | $1,426,000 | thousands by filing date | |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 110,532 | $1,115,000 | thousands by filing date | |
| CURIS INC | 231269200 | COM | 1,500,000 | $1,056,000 | thousands by filing date | |
| RIGEL PHARMACEUTICALS INC | 766559603 | COMMON STOCK | 350,000 | $546,000 | thousands by filing date | |
| LEAP THERAPEUTICS INC | 52187K101 | COM | 250,000 | $395,000 | thousands by filing date |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001053906-20-000006 | this filing | 2020-05-14 | acceptance time not in the bulk data set |